Teva Pharmaceutical Industries has denied an Israeli media report that Chief Executive Jeremy Levin was considering resigning due to a rift with the company’s board of directors. “These are baseless claims,” Israel-based Teva, the world’s largest generic drugmaker, said in an emailed statement on Monday. Channel 2 television quoted unnamed sources as saying there were strong differences of opinion between Levin and Chairman Phillip Frost over the implementation of Teva’s new strategy.
Help employers find you! Check out all the jobs and post your resume.
